Top Banner
Best Practices in Best Practices in Drug Courts Drug Courts Douglas B. Marlowe, J.D., Douglas B. Marlowe, J.D., Ph.D. Ph.D. National Association of Drug Court National Association of Drug Court Professionals Professionals
56

Douglas B. Marlowe, J.D., Ph.D.

Jan 03, 2016

Download

Documents

channing-vega

Best Practices in Drug Courts. National Association of Drug Court Professionals. Douglas B. Marlowe, J.D., Ph.D. Meta-Analyses. Crime Reduced on Avg . by. Institution. Number of Drug Courts. Citation. Wilson et al. (2006). Campbell Collaborative. 14% to 26%. Latimer et al. (2006). - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Douglas B. Marlowe, J.D., Ph.D.

Best Practices in Best Practices in Drug CourtsDrug Courts

Douglas B. Marlowe, J.D., Ph.D.Douglas B. Marlowe, J.D., Ph.D.National Association of Drug CourtNational Association of Drug Court

ProfessionalsProfessionals

Page 2: Douglas B. Marlowe, J.D., Ph.D.

Meta-AnalysesMeta-Analyses

CitatioCitationn

InstitutioInstitutionn

Number of Number of

Drug Drug CourtsCourts

Crime Crime ReducedReduced

on on AvgAvg. by . . .. by . . .

Wilson et al. Wilson et al. (2006)(2006)

Campbell Campbell CollaborativCollaborativee

5555

14% to 14% to 26%26%

Latimer et al. Latimer et al. (2006)(2006)

Canada Dept. Canada Dept. ofofJusticeJustice

6666

1414%%

Shaffer Shaffer (2006)(2006)

University University of of NevadaNevada

7766

9%9%

Lowenkamp et Lowenkamp et al.al.(2005)(2005)

University University of of CincinnatiCincinnati

2222

8%8%

8%8%

Aos et al. Aos et al. (2006)(2006)

Washington State Washington State Inst.Inst. for Public Policyfor Public Policy

5577

Page 3: Douglas B. Marlowe, J.D., Ph.D.

Cost AnalysesCost Analyses

CitatioCitationn

AvgAvg. Benefit . Benefit Per Per

$1 Invested$1 Invested

Loman Loman (2004)(2004)

$2.80 to $2.80 to $6.32$6.32

Finigan et al. Finigan et al. (2007)(2007)

$6,744 to $6,744 to $12,218$12,218

Carey et al. Carey et al. (2006)(2006)

$11,00$11,0000

Barnoski & AosBarnoski & Aos(2003)(2003)

$1.7$1.744

Aos et al. Aos et al. (2006)(2006)

N/N/AA

AvgAvg. Cost . Cost Saving Saving

Per ClientPer Client

$4,767$4,767

$2,888$2,888

$2,615 to $7,707 $2,615 to $7,707

$3.50$3.50

$2.63$2.63

Bhati et al. Bhati et al. (2008)(2008)

$2.2$2.211

No. Drug No. Drug CourtsCourts

1 (St. 1 (St. Louis)Louis)

1 (Portland, OR)1 (Portland, OR)

9 (California)9 (California)

5 (Washington St.)5 (Washington St.)

National DataNational Data

N/N/AA

National DataNational Data

Page 4: Douglas B. Marlowe, J.D., Ph.D.

Best Practices ResearchBest Practices Research**Shannon Carey et al. (2008). Shannon Carey et al. (2008). Exploring the key components of drug courts: A Exploring the key components of drug courts: A comparative study of 18 adult drug courts on practices, outcomes and costscomparative study of 18 adult drug courts on practices, outcomes and costs . Portland, . Portland, OR: NPC Research.OR: NPC Research.

**Shannon Carey et al. (2008). Shannon Carey et al. (2008). Drug courts and state mandated drug treatment programs: Drug courts and state mandated drug treatment programs: Outcomes, costs and consequencesOutcomes, costs and consequences. . Portland, OR: NPC Research.Portland, OR: NPC Research.

**Michael Finigan et al. (2007). Michael Finigan et al. (2007). The impact of a mature drug court over 10 years of The impact of a mature drug court over 10 years of operation: Recidivism and costsoperation: Recidivism and costs. Portland, OR: NPC Research.. Portland, OR: NPC Research.

Deborah Shaffer (2006). Deborah Shaffer (2006). Reconsidering drug court effectiveness: A meta-analytic Reconsidering drug court effectiveness: A meta-analytic reviewreview. Las Vegas, NV: Dept. of Criminal Justice, University of Nevada.. Las Vegas, NV: Dept. of Criminal Justice, University of Nevada.

** www.npcresearch.com www.npcresearch.com

Page 5: Douglas B. Marlowe, J.D., Ph.D.

Key Component #1

“Realization of these [rehabilitation] goals requires a team approach, including

cooperation and collaboration of the judges, prosecutors, defense counsel, probation

authorities, other corrections personnel, law enforcement, pretrial services agencies, TASC programs, evaluators, an array of local service

providers, and the greater community.”

Page 6: Douglas B. Marlowe, J.D., Ph.D.

Team InvolvementTeam Involvement

• Is it important for the attorneys to attend team meetings (“staffings”)?

Page 7: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Required a Treatment Representative at Court Hearings Had 9 Times Greater Savings

p<.05

Page 8: Douglas B. Marlowe, J.D., Ph.D.

*p<.05

Drug Courts That Expected the Public Defender to Attend All Team Meetings Had 8 Times

Greater Savings

Page 9: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts That Expected the Prosecutor to Attend All Team Meetings Had More Than 2

Times Greater Savings

Page 10: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts that Included Law Enforcement as a Member of the Team Had Greater Cost Savings

Note: Difference is significant at p<.05

Page 11: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Required All Team Members to Attend Staffings Had Twice the Savings

Note 1: Difference is significant at p<.05

Note 2: “Team Members” = Judge, Both Attorneys, Treatment Provider, Coordinator

Page 12: Douglas B. Marlowe, J.D., Ph.D.

Does allowing non-drug charges threaten public safety?

Non-Drug ChargesNon-Drug Charges

Page 13: Douglas B. Marlowe, J.D., Ph.D.

Note 1: Difference is significant at p<.05

Drug Courts That Accepted Participants With Non-Drug Charges Had Nearly Twice the Savings

Note 2: Non-drug charges include property, prostitution, violence, etc.

Page 14: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is NOT significant

Drug Courts That Accepted Participants with Prior Violence Had No Differences in Graduation

Rates

Page 15: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is NOT significant

Drug Courts That Accepted Participants with Prior Violence Had No Differences in Cost

Savings

Page 16: Douglas B. Marlowe, J.D., Ph.D.

Key Component #3

“Eligible participants are identified early and promptly placed in the

drug court program.”

Page 17: Douglas B. Marlowe, J.D., Ph.D.

• Is it really important to get participants into the program quickly? And what is quickly?

Prompt TreatmentPrompt Treatment

Page 18: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts In Which Participants Entered the Program Within 20 Days of Arrest Had Twice the

Savings

Page 19: Douglas B. Marlowe, J.D., Ph.D.

Key Component #4

Drug courts provide access to a continuum of alcohol, drug, and other

related treatment and rehabilitation services.

Page 20: Douglas B. Marlowe, J.D., Ph.D.

• How important is relapse prevention?

Effective TreatmentEffective Treatment

• Is it better to have a single treatment agency or to have multiple treatment options?

Page 21: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Used a Single Coordinating Treatment Agency Had 10 Times Greater Savings

Note: Difference is significant at p<.05

Page 22: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Included a Phase Focusing on Relapse Prevention Had Over 3 Times Greater

Savings

Note: Difference is significant at p<.05

Page 23: Douglas B. Marlowe, J.D., Ph.D.

Key Component #7

“Ongoing judicial interaction with each drug court participant is

essential.”

Page 24: Douglas B. Marlowe, J.D., Ph.D.

• How long should the judge stay on the drug court bench? Is longevity better or is it better to rotate regularly?

The JudgeThe Judge

• How often should participants appear before the judge?

Page 25: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Held Status Hearings Every 2 Weeks During Phase 1 Had 2 Times

Greater Cost Savings

Note: Difference is significant at p<.05

Page 26: Douglas B. Marlowe, J.D., Ph.D.

Different judges had different impacts on recidivism

8%

27%

4%

28%

42%

30%

34%

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

Judge 1A Judge 2 Judge 3A Judge 3B Judge 1B Judge 4 Judge 5

% im

prov

emen

t in

# of

re-

arre

sts

The Longer the Judge Spent on the Drug Court Bench, the Better the Client

Outcomes

Page 27: Douglas B. Marlowe, J.D., Ph.D.

Different judges had different impacts on recidivism Judges did better their second timeJudges did better their second time

8%

27%

4%

28%

42%

30%

34%

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

Judge 1A Judge 2 Judge 3A Judge 3B Judge 1B Judge 4 Judge 5

% im

prov

emen

t in

# of

re-

arre

sts

The Longer the Judge Spent on the Drug Court Bench, the Better the Client

Outcomes

Page 28: Douglas B. Marlowe, J.D., Ph.D.

8%

27%

4%

28%

42%

30%

34%

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

Judge 1A Judge 2 Judge 3A Judge 3B Judge 1B Judge 4 Judge 5

% im

prov

emen

t in

# of

re-

arre

sts

Different judges had different impacts on recidivism Judges did better their second timeJudges did better their second time

The Longer the Judge Spent on the Drug Court Bench, the Better the Client

Outcomes

Page 29: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Have Judges Stay Longer Than Two Years Had 3 Times

Greater Cost Savings

Note: Difference is significant at p<.05

Page 30: Douglas B. Marlowe, J.D., Ph.D.

Judges Who Spent at Least 3 Minutes Talking to Each Participant in Court Had

More Than Twice the Savings

Note: Difference is significant at p<.1

Page 31: Douglas B. Marlowe, J.D., Ph.D.

Key Component #5

“Abstinence is monitored by frequent alcohol and other drug testing.”

Page 32: Douglas B. Marlowe, J.D., Ph.D.

Drug TestingDrug Testing

• How frequently should participants be tested?

• How quickly should results be available to the team?

Page 33: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Performed Drug Testing 2 or More Times Per Week During Phase 1 Had Savings

Note: Difference is significant at p<.05

Page 34: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts That Received Drug Test Results Within 48 Hours Had 3 Times Greater Savings

Page 35: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts That Required Greater Than 90 Days of Abstinence Had Larger Cost Savings

Page 36: Douglas B. Marlowe, J.D., Ph.D.

Key Component #6

“Drug courts establish a coordinated strategy, including a continuum of

responses, to continuing drug use and other noncompliant behavior . . .

Reponses to or sanctions for noncompliance might include . . .

escalating periods of jail confinement”

Page 37: Douglas B. Marlowe, J.D., Ph.D.

• Do your guidelines on team responses to client behavior really need to be in writing?

Written Sanction and Written Sanction and Incentive GuidelinesIncentive Guidelines

Page 38: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts That Had Written Rules for Team Responses Had Nearly 3 Times the

Cost Savings

Page 39: Douglas B. Marlowe, J.D., Ph.D.

• How important is jail as a sanction?

JailJail

Page 40: Douglas B. Marlowe, J.D., Ph.D.

Drug court with same judge and same team had better outcomes for participants when the option of jail as a sanction was available

Participants Facing the Possibility of Jail as a Sanction Had Lower Recidivism

2.4

4.2

5.7

2

3

4

0

1

2

3

4

5

6

Year 1 Year 2 Year 3

Ave

rag

e n

um

ber

of R

e-A

rres

ts p

er

Par

ticip

ant Drug Court

No JailN = 60

Drug Court with JailN = 68

Page 41: Douglas B. Marlowe, J.D., Ph.D.

Key Component #9

“Continuing interdisciplinary education promotes effective drug court planning,

implementation, and operations.”

Page 42: Douglas B. Marlowe, J.D., Ph.D.

• How important is formal training for team members?

• Who should be trained?

TrainingTraining

• When should team members get trained?

Page 43: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts That Provided Formal Training for All Team Members Had 5 Times Greater Savings

All Drug Court Team Members Get Formal Training

8%

41%

0%

10%

20%

30%

40%

50%

YesN=6

NoN=7

* "Percent improvement in outcome costs" refers to the percent savings for drug court compared to business-as-usual

Perc

ent I

mpr

ovem

ent i

n O

utco

me

Cost

s*

Page 44: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant at p<.05

Drug Courts That Received Training Prior to Implementation Had 15 Times Greater Cost Savings

Page 45: Douglas B. Marlowe, J.D., Ph.D.

Key Component #8

“Monitoring and evaluation measure the achievement of program goals and gauge

effectiveness.”

Page 46: Douglas B. Marlowe, J.D., Ph.D.

• Does it matter whether data are kept in paper files or in a database?

Monitoring and EvaluationMonitoring and Evaluation

• Does keeping program stats make a difference?

• Do you really need an evaluation? What do you get out of it?

Page 47: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Used Paper Files Rather Than Electronic Databases Had Less Savings

Note: Difference is significant at p<.05

Page 48: Douglas B. Marlowe, J.D., Ph.D.

Drug Courts That Used Evaluation Feedback to Make Modifications Had 4 Times Greater Cost

Savings

Note: Difference is significant at p<.05

Page 49: Douglas B. Marlowe, J.D., Ph.D.

Key Component #10

“Forging partnerships among drug courts, public agencies, and community-based

organizations generates local support and enhances drug court program

effectiveness.”

Page 50: Douglas B. Marlowe, J.D., Ph.D.

• How important are partnerships in the community for your drug court?

Community PartnershipsCommunity Partnerships

Page 51: Douglas B. Marlowe, J.D., Ph.D.

Note: Difference is significant as a trend at p<.15

Drug Courts That Had Formal Partnerships with Community Organizations Had More than Twice the

Savings

Page 52: Douglas B. Marlowe, J.D., Ph.D.

Recipes for FailureRecipes for Failure

• Water down the interventionWater down the intervention– Drop essential elementsDrop essential elements

– Accept imitationsAccept imitations

““It’s not It’s not scalable”scalable”

““We’re just We’re just like a drug like a drug

court”court”

Page 53: Douglas B. Marlowe, J.D., Ph.D.

Recipes for FailureRecipes for Failure

• Change course with new Change course with new populations populations ““It won’t It won’t

work here”work here”

““My clients My clients are different”are different”

Page 54: Douglas B. Marlowe, J.D., Ph.D.

Recipes for FailureRecipes for Failure

• Stepped CareStepped Care– Start with less and ratchet up if you need toStart with less and ratchet up if you need to

““It’s less It’s less burdensome burdensome on clients”on clients”

““It’s more It’s more economical”economical”

Page 55: Douglas B. Marlowe, J.D., Ph.D.

Recipes for FailureRecipes for Failure

• Target the wrong peopleTarget the wrong people– 1st-time offenders1st-time offenders

– Low risk and low needsLow risk and low needs

““It’s safer”It’s safer”

““It’s a form of It’s a form of prevention”prevention”

““They’re more They’re more deserving”deserving”

Page 56: Douglas B. Marlowe, J.D., Ph.D.

Recipe for SuccessRecipe for Success

• Send us the high-value casesSend us the high-value cases

• Fidelity to the Fidelity to the 10 Key Components10 Key Components until proven otherwise!until proven otherwise!

• Ongoing judicial authorityOngoing judicial authority

• Inter-agency team approachInter-agency team approach

• Branching model Branching model

– Get it right the Get it right the firstfirst time time